Showing results (161-170 of 344) with videos related to
Sort By:
Pageof 35
Cancer Research and Treatment|November 19, 2016
A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell CarcinomaSung Hee Lim, Young Mog Shim, Se Hoon Park, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2013
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapySeung Hwan Moon, Su-Hee Cho, Lee Chun Park, et al.The Oncologist|May 29, 2014
Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFRMyung-Ju Ahn, Sang-We Kim, Byoung-Chul Cho, et al.Cancer Research and Treatment|January 24, 2014
Tumor lysis syndrome in a solid tumor: a case report of a patient with invasive thymomaJi Yun Lee, Sung Hee Lim, Ji Young Lee, et al.European Journal of Cancer (Oxford, England : 1990)|September 8, 2019
Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencingHong Sook Kim, Hongui Cha, Jinho Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2010
Who are less likely to receive subsequent chemotherapy beyond first-line therapy for advanced non-small cell lung cancer? Implications for selection of patients for maintenance therapyJong-Mu Sun, Joon Oh Park, Young-Woong Won, et al.Cancer|June 22, 2010
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapySeung Tae Kim, Jeeyun Lee, Jeong-Hoon Kim, et al.Lung Cancer (Amsterdam, Netherlands)|July 6, 2010
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastasesJong-Mu Sun, Jin Seok Ahn, Soohyeon Lee, et al.Nature Communications|September 21, 2019
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number loadHyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLCYoujin Kim, Boram Lee, Joon Ho Shim, et al.Pageof 35